Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL23152702 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL28717147 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL28204782 | 0.82 | — | — | |
| Hydrochloric Acid SCHEMBL239818 | 0.71 | — | — | |
| Hydrochloric Acid SCHEMBL43 | 0.71 | — | — | |
| Hydrochloric Acid SCHEMBL11388144 | 0.71 | — | — | |
| Hydrochloric Acid SCHEMBL8183797 | 0.71 | CA4 (1.00) | — | |
| Hydrochloric Acid SCHEMBL2444651 | 0.71 | — | — | |
| Hydrochloric Acid SCHEMBL630599 | 0.71 | — | — | |
| Hydrochloric Acid SCHEMBL125 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 648 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119370800-A | Method for preparing deuterated hydrochloric acid | 四川新火炬化工有限责任公司 | 2025-01-28 | — | — | CN | claimed |
| CN-115784159-B | Method for preparing deuterium chloride | 派瑞科技有限公司 | 2024-07-19 | — | — | CN | claimed |
| EP-4285900-A2 | CRYSTALLINE FORMS OF DEUTERIUM-ENRICHED PIOGLITAZONE | Poxel SA (FR) | 2023-12-06 | — | — | EP | claimed |
| US-20230373913-A1 | Methods of Making Deuterium-Enriched N-Acetylcysteine Amide (D-NACA) and (2R,2R)-3,3-Disulfanediyl BIS(2-Acetamidopropanamide) (DINACA) and Using D-NACA and DINACA to Treat Diseases Involving Oxidative Stress | NACUITY PHARMACEUTICALS, INC. | 2023-11-23 | — | — | US | claimed |
| CN-115141103-B | Perdeuterated 1, 1-diamino-2, 2-dinitroethylene and preparation method and application thereof | 理道新材(北京)科技有限公司 | 2023-06-16 | — | — | CN | claimed |
| CN-114870892-B | Chiral binaphthyl catalyst and preparation method and application thereof | 上海交通大学 | 2023-04-28 | — | — | CN | claimed |
| CN-115784159-A | Method for preparing deuterium chloride | 派瑞科技有限公司 | 2023-03-14 | — | — | CN | claimed |
| CN-115784827-A | Method for preparing deuterated benzene | 派瑞科技有限公司 | 2023-03-14 | — | — | CN | claimed |
| US-20230074827-A1 | CRYSTALLINE FORMS OF DEUTERIUM-ENRICHED PIOGLITAZONE | POXEL SA (FR) | 2023-03-09 | — | — | US | claimed |
| CN-115141103-A | Perdeuterated 1, 1-diamino-2, 2-dinitroethylene and preparation method and application thereof | 理道新材(北京)科技有限公司 | 2022-10-04 | — | — | CN | claimed |
| CN-102532132-A | Perylene acid addition salt of moxifloxacin | BEIJING KAWEI BIO PHARMACEUTICAL TECHNOLOGY CO LTD | 2012-07-04 | — | — | CN | claimed |
| EP-2421867-A2 | PIPERIDINE INHIBITORS OF JANUS KINASE 3 | Auspex Pharmaceuticals, Llc (US) | 2012-02-29 | — | — | EP | claimed |
| US-20110034479-A1 | Deuterium-enriched alkyl sulfonamides | DHANOA DALJIT SINGH | 2011-02-10 | — | — | US | claimed |
| US-20100291026-A1 | PIPERIDINE INHIBITORS OF JANUS KINASE 3 | AUSPEX PHARMACEUTICALS, INC. (US) | 2010-11-18 | — | — | US | claimed |
| WO-2010123919-A2 | PIPERIDINE INHIBITORS OF JANUS KINASE 3 | AUSPEX PHARMACEUTICALS, LLC (US) | 2010-10-28 | — | — | WO | claimed |
| US-7453917-B1 | Supersonic all gas-phase iodine laser | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE (US) | 2008-11-18 | — | — | US | claimed |
| US-7158554-B2 | Methods and apparatus for regenerating fuels in a solid generator chemical oxygen iodine laser | THE BOEING COMPANY (US) | 2007-01-02 | — | — | US | claimed |
| US-20050025209-A1 | Methods and apparatus for regenerating fuels in a solid generator chemical oxygen iodine laser | BOEING COMPANY, THE | 2005-02-03 | — | — | US | claimed |
| US-6623718-B1 | Reacting solid peroxide and nonradioactive hydrogen isotope halide gas at ambient temperature and without external energy source | ERC INCORPORATED | 2003-09-23 | — | — | US | claimed |
| US-6459717-B1 | Continuous wave all gas phase iodine laser (AGIL) | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE | 2002-10-01 | — | — | US | claimed |